Analyzing lung tissue samples to improve chronic lung disease diagnosis
Part of Lungs & breathing clinical trials.
This study uses a new imaging technology called LIBS to examine lung tissue samples that were already removed as part of your regular care. The goal is to see if this method can help doctors better understand and diagnose chronic lung diseases like interstitial lung disease, sarcoidosis, or emphysema.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with or show signs of a chronic (long-term) lung disease such as interstitial lung disease, sarcoidosis, or emphysema
- You had a lung tissue biopsy (small sample taken during a procedure) as part of your regular medical care, and that sample is still available and stored properly
- Your medical records contain enough information about your health history, work or environmental exposures, smoking habits, and test results
- You have not objected to researchers using your stored tissue sample and health information for this research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
This study uses a fluid sample taken from your lungs (called bronchoalveolar lavage) to understand the specific types of inflammation in different forms of interstitial lung disease. This may help doctors tailor better treatments for you in the future.
This study builds a “biobank,” a storage of blood and related samples, from people with lung interstitial lung diseases or other lung scarring diseases. Your samples help researchers study these conditions and improve future care.
This study tests a lung biopsy method that uses ultrasound to guide a needle through the chest wall to take a small tissue sample. The goal is to see if it's safe for people with diffuse interstitial lung disease, which may help doctors get a more accurate diagnosis.
This is an observational (non-treatment) study that collects information about how interstitial lung disease (lung scarring) happens in people with certain autoimmune or immune-related conditions. It uses patient interviews or existing medical records to better understand the pattern and causes, which may help future care.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
Hear when a new Environmental Exposure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.